Compare PMVP & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMVP | HNNA |
|---|---|---|
| Founded | 2013 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.9M | 76.4M |
| IPO Year | 2020 | N/A |
| Metric | PMVP | HNNA |
|---|---|---|
| Price | $1.13 | $9.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 255.3K | 13.3K |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | N/A | ★ 5.85% |
| EPS Growth | N/A | ★ 38.04 |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $35,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.40 |
| Revenue Growth | N/A | ★ 19.88 |
| 52 Week Low | $0.81 | $8.43 |
| 52 Week High | $1.84 | $13.88 |
| Indicator | PMVP | HNNA |
|---|---|---|
| Relative Strength Index (RSI) | 33.18 | 44.56 |
| Support Level | $1.14 | $9.35 |
| Resistance Level | $1.30 | $10.20 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 2.08 | 38.52 |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.